PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
Yan Fang(Shanghai Jiao Tong University), Jianfeng Shen(Shanghai Jiao Tong University)
Cited by 0
Related Papers
PARPi triggers STING-dependent immune response and enhances therapeutic efficacy of immune checkpoint blockade independent of BRCAness
|bioRxiv (Cold Spring Harbor Laboratory)|2018|7
BAP1 inactivation promotes lactate production by leveraging the subcellular localization of LDHA in melanoma
|Cell Death Discovery|2024|6